| Identification | Back Directory | [Name]
Cyclohexanebutanoicacid, a-hydroxy-b-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2R)-4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl]amino]-1-oxopropyl]amino]-,1-methylethyl ester, (aR,bS)- | [CAS]
128053-53-2 | [Synonyms]
Cyclohexanebutanoicacid, a-hydroxy-b-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2R)-4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl]amino]-1-oxopropyl]amino]-,1-methylethyl ester, (aR,bS)- | [Molecular Formula]
C38H51N5O7 | [MOL File]
128053-53-2.mol | [Molecular Weight]
689.85 |
| Hazard Information | Back Directory | [Description]
Kri 1314 is a cyclohexyl-norstatine-containing dipeptide renin inhibitor which has potential for the treatment of hypertension. |
|
|